Ray Dalio's NUVL Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 18,578 shares of Nuvalent, Inc. (NUVL) worth $1.87 M, representing 0.01% of the portfolio. First purchased in 2025-Q3, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Ray Dalio has initiated a new position in NUVL, representing a fresh investment thesis on this company. Largest reduction occurred in Q4 2025, reducing 3,479 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Nuvalent (NUVL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Nuvalent (NUVL) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -3,479 | Reduce 15.77% | 18,578 | $100.59 |
| Q3 2025 | +22,057 | New Buy | 22,057 | $86.48 |
Ray Dalio's Nuvalent Investment FAQs
Ray Dalio first purchased Nuvalent, Inc. (NUVL) in Q3 2025, acquiring 22,057 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Nuvalent, Inc. (NUVL) for 2 quarters since Q3 2025.
Ray Dalio's largest addition to Nuvalent, Inc. (NUVL) was in Q3 2025, adding 22,057 shares worth $1.91 M.
According to the latest 13F filing for Q4 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 18,578 shares of Nuvalent, Inc. (NUVL), valued at approximately $1.87 M.
As of the Q4 2025 filing, Nuvalent, Inc. (NUVL) represents approximately 0.01% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Nuvalent, Inc. (NUVL) was 22,057 shares, as reported at the end of Q3 2025.